AF
ADN

Amalgamated Financial’s Advent Technologies ADN Stock Holding History

Amalgamated Financial’s Portfolio ADN Stock Details ADN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6K Buy
+82
New +$9.29K ﹤0.01% 2948

Other funds holding ADN

BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Financial's ADN Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Advent Technologies (ADN) in Q1 2022: 82 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #2948 among its holdings.

71 funds tracked by Wall St. Rank hold ADN as of Q1 2022.

  • Amalgamated Financial held 82 shares of Advent Technologies worth $6K as of Q1 2022.
  • Advent Technologies was a new Amalgamated Financial position in Q1 2022.
  • Advent Technologies made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2948 holding.
  • 71 funds tracked by Wall St. Rank held Advent Technologies as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.